Can Quidel Corporation (QDEL)’s Tomorrow be Different? The Stock Just Broke Its High

May 20, 2018 - By Nellie Frank

Investors sentiment decreased to 1.17 in 2017 Q4. Its down 0.03, from 1.2 in 2017Q3. It turned negative, as 18 investors sold Quidel Corporation shares while 35 reduced holdings. 27 funds opened positions while 35 raised stakes. 30.94 million shares or 0.83% more from 30.68 million shares in 2017Q3 were reported.
State Board Of Administration Of Florida Retirement System, a Florida-based fund reported 17,770 shares. Ameritas Investment Partners Inc accumulated 2,221 shares. Parallax Volatility Advisers L P holds 0% or 4,242 shares. Zebra Cap Ltd Limited Liability Company holds 0.15% of its portfolio in Quidel Corporation (NASDAQ:QDEL) for 10,049 shares. Rhumbline Advisers accumulated 28,471 shares. Invesco Ltd reported 77,709 shares stake. Credit Suisse Ag accumulated 32,070 shares. Aristotle Capital Boston Lc has invested 0.99% in Quidel Corporation (NASDAQ:QDEL). Nicholas Inv Prtn L P owns 102,985 shares for 0.29% of their portfolio. Nelson Roberts Advsrs Limited Liability Company holds 300 shares. Quantbot Lp stated it has 5,101 shares or 0.02% of all its holdings. First Light Asset Mngmt Ltd Liability Corporation owns 1.43% invested in Quidel Corporation (NASDAQ:QDEL) for 119,901 shares. Zurcher Kantonalbank (Zurich Cantonalbank) holds 2,385 shares or 0% of its portfolio. Comml Bank Of Ny Mellon Corp owns 172,795 shares. Ny State Common Retirement Fund stated it has 899,100 shares or 0.05% of all its holdings.

Since December 8, 2017, it had 0 insider purchases, and 10 insider sales for $15.81 million activity. BRYANT DOUGLAS C also sold $1.69M worth of Quidel Corporation (NASDAQ:QDEL) on Monday, January 29. 29,880 shares valued at $1.35M were sold by BORKAR RATAN S on Wednesday, January 3. SCHULER JACK W had sold 12,000 shares worth $582,031 on Monday, January 22. The insider STEWARD RANDALL J sold $1.46 million. Another trade for 16,358 shares valued at $661,529 was made by Kroll Werner on Friday, December 8.

The stock of Quidel Corporation (NASDAQ:QDEL) hit a new 52-week high and has $67.81 target or 6.00 % above today’s $63.97 share price. The 5 months bullish chart indicates low risk for the $2.40 billion company. The 1-year high was reported on May, 20 by Barchart.com. If the $67.81 price target is reached, the company will be worth $143.76 million more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

The stock increased 1.14% or $0.72 during the last trading session, reaching $63.97. About 260,576 shares traded. Quidel Corporation (NASDAQ:QDEL) has risen 128.16% since May 20, 2017 and is uptrending. It has outperformed by 116.61% the S&P500.

Analysts await Quidel Corporation (NASDAQ:QDEL) to report earnings on July, 25. They expect $0.22 earnings per share, up 162.86 % or $0.57 from last year’s $-0.35 per share. QDEL’s profit will be $8.24 million for 72.69 P/E if the $0.22 EPS becomes a reality. After $1.23 actual earnings per share reported by Quidel Corporation for the previous quarter, Wall Street now forecasts -82.11 % negative EPS growth.

Quidel Corporation (NASDAQ:QDEL) Ratings Coverage

Among 8 analysts covering Quidel Corp (NASDAQ:QDEL), 8 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Quidel Corp had 11 analyst reports since December 21, 2017 according to SRatingsIntel. The rating was maintained by William Blair on Friday, April 13 with “Buy”. On Monday, March 26 the stock rating was initiated by Craig Hallum with “Buy”. The firm has “Buy” rating given on Thursday, April 5 by Canaccord Genuity. The stock of Quidel Corporation (NASDAQ:QDEL) has “Buy” rating given on Tuesday, April 3 by Piper Jaffray. The firm has “Buy” rating by C.L. King given on Thursday, January 4. The rating was maintained by Barclays Capital on Monday, January 22 with “Buy”. The firm has “Strong Buy” rating by Raymond James given on Thursday, March 8. As per Thursday, January 4, the company rating was upgraded by CL King. Barclays Capital maintained it with “Overweight” rating and $63 target in Monday, April 2 report. As per Thursday, December 21, the company rating was maintained by Canaccord Genuity.

More news for Quidel Corporation (NASDAQ:QDEL) were recently published by: Businesswire.com, which released: “Quidel to Present at UBS Global Healthcare Conference” on May 15, 2018. Seekingalpha.com‘s article titled: “Quidel’s (QDEL) CEO Doug Bryant on Q1 2018 Results – Earnings Call Transcript” and published on May 09, 2018 is yet another important article.

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications primarily in infectious diseases, POC womenÂ’s and general health, and gastrointestinal diseases. The company has market cap of $2.40 billion. The firm offers Sofia influenza A+B and QuickVue influenza tests to detect viral antigens of influenza type A and B; Sofia strep A fluorescent immunoassay and QuickVue Strep A tests to detect group A Streptococcal antigen from throat swabs; and Sofia Respiratory Syncytial Virus , QuickVue RSV, and Quidel Molecular RSV + human metapneumovirus tests for respiratory syncytial virus. It currently has negative earnings. It also provides various products to detect various herpes simplex virus (HSV) and herpes family viruses; H&V-Mix to isolate HSV, VZV, and Cytomegalovirus; R-Mix to detect Influenza A and B, RSV, Adenovirus, and Parainfluenza types 1, 2, and 3; Sofia S.

Quidel Corporation (NASDAQ:QDEL) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.